Xcout Intel
Axonis Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Axonis Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Axonis Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Axonis Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Axonis Therapeutics, Inc.
Axonis Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on discovering and developing novel treatments for neurological conditions and spinal cord injuries. Founded in 2019, the company advances therapeutic candidates through its proprietary research platform.
Axonis Therapeutics, Inc. at a glance
Axonis Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $125M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $120M in October 2024. Xcout tracks 13 named people at Axonis Therapeutics, Inc., including JEFF IMBARO (Chief Operating Officer).
Axonis Therapeutics, Inc. leadership
- JEFF IMBAROChief Operating Officer
- Jeffrey ImbaroChief Operating Officer
- Joanna StanickaCEO, President & Co-Founder
- SHANE V. HEGARTYChief Scientific Officer & Co-Founder
- Donald J. Manning, M.D., Ph.DExecutive Officer
- Donald Manning, M.D., Ph.DExecutive Officer
7 more named people on record for Axonis Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Axonis Therapeutics, Inc. funding rounds
At least $125M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $120M | 14 named | |
| Series A | $5M | 14 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Axonis Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Axonis Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
Life Sciences
AZTherapies, Inc. is a private, late-stage clinical biopharmaceutical company founded in 2011 and headquartered in Boston, Massachusetts. The company focuses on developing novel treatments for devastating neurological conditions.
Biotech
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.
Similar biotechnology company
Atalanta Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, focused on developing RNA-interference therapeutic interventions for neurodegenerative diseases. The company launched with significant venture backing from life sciences investors.
Similar biotechnology company
AstronauTx is a clinical-stage biotechnology company headquartered in London, United Kingdom. Founded in 2019, the firm develops novel small-molecule drugs aimed at treating neurodegenerative conditions such as Alzheimer's disease by targeting glial cell dysfunction.
Similar biotechnology company
Solvonis Therapeutics plc is a biopharmaceutical company that develops novel medicines for central nervous system (CNS) disorders. Its initial therapeutic focus is on treating Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), with discovery programs extending into broader addiction, psychiatry, and neurology fields.
Similar biotechnology company
Delix Therapeutics is a privately held biopharmaceutical company headquartered in Boston, Massachusetts, focused on transforming the treatment of brain health through neuroscience.
Biotech
NeuroX1 Inc. is a for-profit biotechnology startup founded in 2021 with headquarters in Austin, Texas, operating a target identification and drug discovery platform that utilizes proprietary technology.
Similar biotechnology company
Harness Therapeutics Ltd. is a biotechnology company founded in 2023 and based in Cambridge, United Kingdom. The company focuses on RNA biology and the development of novel therapeutics for the treatment of neurodegenerative diseases.
Similar biotechnology company
Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing novel therapeutics to address central nervous system and other conditions.
Similar biotechnology company
Sironax is a biopharmaceutical company committed to developing new treatments by targeting underlying contributors of degeneration, including neurodegenerative, inflammatory, and metabolic disorders.
Similar biotechnology company
Ignis Therapeutics is a biotechnology company established in late 2020 and headquartered in Shanghai, China. The company is dedicated to discovering and developing therapeutics for central nervous system (CNS) diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Axonis Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Axonis Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →